(Q35146591)

6 August 2017

1 reference

title

Angiogenesis, lymphangiogenesis, and melanoma metastasis (English)

1 reference

6 August 2017

1 reference

1 reference

2

Michael Detmar

1 reference

6 August 2017

Michael Streit

1

1 reference

PubMed ID

12789293

6 August 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

6 August 2017

1 reference

6 August 2017

22

1 reference

6 August 2017

3172-3179

1 reference

6 August 2017

20

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1206457

6 August 2017

0 references

cites work

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Inhibition of the alpha-nu integrins with a cyclic RGD peptide impairs angiogenesis, growth and metastasis of solid tumours in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85-1.25 mm in thickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

The formation of lymphatic vessels and its importance in the setting of malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Clinical applications of angiogenic growth factors and their inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Tumor angiogenesis: a possible control point in tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Looking for a good endothelial address

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Melanoma-associated expression of vascular endothelial growth factor and its receptors FLT-1 and KDR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Temozolomide plus thalidomide in patients with advanced melanoma: results of a dose-finding trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Tumor vascularity in the prognostic assessment of primary cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Autocrine and paracrine regulation by cytokines and growth factors in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

From oncogene to drug: development of small molecule tyrosine kinase inhibitors as anti-tumor and anti-angiogenic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Expression of interleukin-8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

A pilot trial of Vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Hypoxia-associated spontaneous pulmonary metastasis in human melanoma xenografts: involvement of microvascular hot spots induced in hypoxic foci by interleukin 8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Enhanced expression of vascular endothelial growth factor in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Genes expressed in human tumor endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

The role of tumor lymphangiogenesis in metastatic spread.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Prognostic value of tumour vascularity in metastatic melanoma and association of blood vessel density with vascular endothelial growth factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Inhibition of angiogenesis and tumour growth by VEGF121-toxin conjugate: differential effect on proliferating endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Suppression of autocrine cell proliferation and tumorigenesis of human melanoma cells and fibroblast growth factor transformed fibroblasts by a kinase-deficient FGF receptor 1: evidence for the involvement of Src-family kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Heterogeneous vascular dependence of tumor cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

7 January 2021

Expression of fibroblast growth factor receptors in naevus-cell naevus and malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

7 January 2021

Expression of platelet-derived growth factor (PDGF)-A, PDGF-B and the PDGF-alpha receptor, but not the PDGF-beta receptor, in human malignant melanoma in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

7 January 2021

What is the most promising strategy for the treatment of metastasizing melanoma?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

7 January 2021

Molecular regulation of angiogenesis in the skin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

7 January 2021

Angiogenic and immune parameters during recombinant interferon-alpha2b adjuvant treatment in patients with melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

7 January 2021

Vascular endothelial growth factor: molecular and biological aspects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

7 January 2021

Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

7 January 2021

Mutant p53 correlates with reduced expression of thrombospondin-1, increased angiogenesis, and metastatic progression in melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

7 January 2021

Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

7 January 2021

Melanoma. Tumor angiogenesis and human neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

7 January 2021

Prognostic value of tumour vascularity in primary melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

7 January 2021

Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

7 January 2021

Administration of a liposomal FGF-2 peptide vaccine leads to abrogation of FGF-2-mediated angiogenesis and tumor development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

7 January 2021

Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

7 January 2021

Tumor angiogenic activity (TAA) production in vitro and growth in the nude mouse by human malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

7 January 2021

Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

7 January 2021

Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206457

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1206457

1 reference

6 August 2017

1 reference

PubMed ID

12789293